Should I cryopreserve my tumor tissue or use FFPE
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
I notice your question about tumor tissue preservation, but I want to make sure I'm giving you the most relevant guidance for your specific situation.
Before I dive into the technical details, could you help me understand the context a bit better?
A few clarifying questions:
-
Who is asking you to decide this? Are you being asked by your healthcare team to choose a preservation method for research purposes, clinical trials, or tumor banking?
-
What's the intended use? Is this for:
- Future genetic/biomarker testing?
- Participation in a research study?
- Tumor banking for potential future treatment decisions?
- Liquid biopsy or other molecular analysis?
-
When is this decision needed? Is this happening at the time of your biopsy or surgery?
Why I'm asking: The choice between cryopreservation (freezing fresh tissue) and FFPE (formalin-fixed paraffin-embedded, the standard preservation method) depends heavily on what your doctors plan to do with the tissue. This isn't typically a patient choice—it's usually determined by your medical team based on the clinical and research needs.
General context: FFPE is the standard method used for routine pathology and diagnosis. Cryopreservation is typically reserved for specific research purposes or biobanking when fresh tissue analysis is needed.
What you should ask your healthcare team:
- "Why are you asking me to choose a preservation method?"
- "What testing or research will be done with my tissue?"
- "What does your lab recommend for my specific situation?"
- "Will this affect my diagnosis or treatment planning?"
Once I understand your situation better, I can provide more targeted educational information about these preservation methods and help you formulate questions for your care team.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I appreciate you sharing these details about your treatment journey. Let me help you understand what's happening and what questions to bring to your o
What signs of progression should I watch for
Based on NCCN Guidelines for Myeloproliferative Neoplasms, here are the key warning signs you should monitor and report to your oncologist: Blood Co
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare for your appointment! To give you the most relevant questions, it would help to know a bit more about your situation: 1.
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
Thank you for the follow-up. I want to address something important that emerged from your medical profile: Your actual diagnosis is a fibroblastic/my
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
I appreciate your question about these specific mutations. However, I want to first clarify something important about your medical profile: Your Situ